ipscell.com
Northwestern abruptly ending Burt HSCT autoimmune trials - The Niche
“HSCT Chicago Clinic Closing!” is the startling header in all caps on a patient-run Facebook page about a stem cell therapy clinical trial program at Northwestern University. What’s going on? Unfortunately, the promising field of hematopoietic stem cell transplantation (HSCT) for multiple sclerosis (MS) and other autoimmune diseases seems to have suffered an unexpected setback … Northwestern abruptly ending Burt HSCT autoimmune trials Read More »
Professor Paul Knoepfler, Ph.D.